Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: A case-control study

British Journal of Cancer

Volumn 73, Issue 12, 1996, Pages 1605-1611

  Bataille, V ^a,c   Newton Bishop, J A ^a   Sasieni, P ^a   Swerdlow, A J ^b   Pinney, E ^a   Griffiths, K ^a   Cuzick, J ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Atypical mole syndrome; Atypical naevi; Case control study; Melanoma

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BUTTOCK; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOOT; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK; SCALP; SCORING SYSTEM; SKIN EXAMINATION; SUN EXPOSURE; UNITED KINGDOM;

EID: 0030037421     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.302     Document Type: Article

References (25)

1. ALBERT DM, SEARL SS, FORGET B, LAVIN PT, KIRKWOOD J AND NORDLUND JJ. (1983). Uveal findings in patients with cutaneous melanoma. Am. J. Ophthalmol., 95, 474-479.
2. ALBERT LS, RHODES AR AND SOBER AJ. (1990). Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives. J. Am. Acad. Dermatol., 22, 69-75.
3. AUGUSTSSON A, STIERNER U, ROSDAHL I AND SUURKULA M. (1991). Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Dermatol. Venereal. (Stockh), 71, 518-524.
4. BLISS JM, FORD D, SWERDLOW AJ, ARMSTRONG HK, CRISTOFOLINI M, ELWOOD JM, GREEN A, HOLLY E, MACK T, MACKIE RM, OSTERLIND A, WALTER SD, PETO J AND EASTON DF. (1995). International Melanoma Analysis Group (IMAGE). Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of ten case control studies. Int. J. Cancer, 62, 367-376.
5. COLEMAN MP, ESTEVE J, DAMIECKI P, ARSLAN A AND RENARD H. (1993). Trends in Cancer Incidence and Mortality. International Agency for Research on Cancer Scientific Publication 121. IARC: Lyon.
6. CLARK WH, REIMER RR, GREENE M, AINSWORTH AM AND MASTRANGELO MJ. (1978). Origin of familial malignant melanoma from heritable melanocytic lesions: the BK mole syndrome. Arch. Dermatol., 114, 732.
7. FITZPATRICK TB. (1988). The validity and practicality of sun reactive skin types 1 through 4. (Editorial). Arch. Dermatol., 124, 869-871.
8. GALLAGHER RP, ELWOOD JM AND HILL GB. (1986). Risk factors for cutaneous malignant melanoma in the Western Canada Melanoma Study. Recent Results Cancer Res., 102, 38-55.
9. GARBE C, BUTTNER P, WEISS J, SOYER HP, STOCKER U, KRUGER S, ROSER M, WECKBECKER J, PANIZZON R, BAHMER F, TILGEN W, GUGGENMOOS-HOLSMAN I AND ORFANOS CE. (1994). Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: mutlicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J. Invest. Dermatol., 102, 695-699.
10. GREENE MH, CLARK JR WH, TUCKER MA, KRAEMER KH, ELDER DE AND FRASER MC. (1995). High risk of malignant melanoma in melanoma-probe families with dysplastic naevi. Ann. Int. Med., 102, 458-465.
11. GREENLAND S. (1987). Variance estimators for attributable fraction estimates, consistent in both large strata and sparse data. Stat. in Med., 6, 701-708.
12. GROB JJ, GOUVERNET J, AYMAR D, MOSTAQUE A, ROMANO MH, COLLET AM, NOE MC, DISCONTANZO MP AND BONERANDI JJ. (1990). Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer, 66, 387-395.
13. HALPERN AC, DUPONT GUERRY, ELDER ED, WALLACE H, CLARK JR, SYNNESTVEDT M, NORMAN S AND AYERLE R. (1991). Dysplastic nevi as risk markers for sporadic non familial melanoma. A case-control study. Arch. Dermatol., 127, 995-999.
14. HALPERN AC, DUPONT-GUERRY IV, ELDER DE, TROCK B AND SYNNESTVEDT M. (1993). A cohort study of melanoma in patients with dysplastic nevi. J. Invest. Dematol., 100, 346S-349S.
15. HOLLY EA, KELLY JW, SHPALL SN AND CHIU SH. (1987). Number of melanocytic nevi as a major risk factor for malignant melanoma. J. Am. Acad. Dermatol., 17, 459-468.
16. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. (1992). IARC Monographs on the Evaluation of Carcinogenesis to Humans. Vol. 55. Solar and Ultraviolet Radiation. IARC: Lyon.
17. KOH HK, KLIGER BE AND LEW RA (1990). Yearly review. Sunlight and cutaneous malignant melanoma: evidence for and against causation. Photochem. Photobiol., 6, 765-779.
18. NEWTON JA, BATAILLE V, GRIFFITHS K, SQUIRE JM, SASIENI P, CUZICK J, BISHOP DT AND SWERDLOW A. (1993). How common is the Atypical Mole Syndrome phenotype in apparently sporadic melanoma. J. Am. Acad. Dermatol., 29, 989-996.
19. NEWTON JA, BATAILLE V, PINNEY E AND BISHOP DT (1994). Family studies in melanoma: identification of the Atypical Mole Syndrome (AMS) phenotype. Mel. Res., 4, 199-206.
20. NORDLUND JJ, KIRKWOOD J, FORGET BM, SCHEIBNER A, ALBERT DM, LERNER E AND MILTON GW. (1985). Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res., 45, 1855-1861.
21. RODRIGUEZ SAINS RS. (1986). Ocular findings in patients with dysplastic nevus syndrome. Ophthalmology, 93, 661-665.
22. SWERDLOW AJ, ENGLISH J, MACKIE RM, O'DOHERTY CJ, CLARK J AND HOLE DJ. (1986). Benign melanocytic naevi as risk factor for malignant melanoma. Br. Med. J., 292, 1555-1559.
23. TRAUPE H, MACHER E, HAMM H AND HAPPLE R. (1989). Mutation rate estimates are not compatible with autosomal dominant inheritance of the dysplastic nevus 'syndrome'. Am. J. Med. Genet., 32, 155-157.
24. TUCKER MA, GREEN MH, CLARK JR WH, KRAEMER KH AND FRASER MC. (1983). Dysplastic nevi in the scalp of prepubertal children from melanoma prone families. J. Pediatr., 103, 65-69.
25. WEINSTOCK MA, STRYKER WS, STAMPFER MJ, LEW RA, WILLETT WC AND SOBER AJ. (1991). Sunlight and dysplastic nevus risk. Results of a clinic-based control study. Cancer, 67, 1701-1706.